Literature DB >> 8624783

Lysophosphatidylcholine potentiates the mitogenic activity of modified LDL for human monocyte-derived macrophages.

M Sakai1, A Miyazaki, H Hakamata, Y Sato, T Matsumura, S Kobori, M Shichiri, S Horiuchi.   

Abstract

The growth of murine peritoneal macrophages is induced by oxidized LDL (Ox-LDL), and lysophosphatidylcholine (lysoPC) plays an important role in its mitogenic activity. In the present++ study, Ox-LDL-induced macrophage growth was examined with human monocyte-derived macrophages. The cell growth of human macrophages was significantly induced by Ox-LDL but not by acetylated LDL (acetyl-LDL). The treatment of acetyl-LDL with phospholipase A2, however, led to a marked increase in its mitogenic activity, with a concomitant conversion of 75% of its phospholipids to lysoPC. The growth-stimulating activity became positive only when both acetyl-LDL and lysoPC were coincubated, although neither of them exhibited cell growth-promoting activity. These results suggest that Ox-LDL could stimulate the growth of human monocyte-derived macrophages, and lysoPC may play an essential role in the mitogenic activity of Ox-LDL.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8624783     DOI: 10.1161/01.atv.16.4.600

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  13 in total

Review 1.  Antiinflammatory and immunomodulatory properties of statins.

Authors:  Ora Shovman; Yair Levy; Boris Gilburd; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Host derived inflammatory phospholipids regulate rahU (PA0122) gene, protein, and biofilm formation in Pseudomonas aeruginosa.

Authors:  Jayasimha Rao; Antonio DiGiandomenico; Mykhaylo Artamonov; Norbert Leitinger; Ashok R Amin; Joanna B Goldberg
Journal:  Cell Immunol       Date:  2011-05-05       Impact factor: 4.868

3.  Investigating the allosterism of acyl-CoA:cholesterol acyltransferase (ACAT) by using various sterols: in vitro and intact cell studies.

Authors:  Jay Liu; Catherine C Y Chang; Emily J Westover; Douglas F Covey; Ta-Yuan Chang
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

4.  Localization of human acyl-coenzyme A: cholesterol acyltransferase-1 (ACAT-1) in macrophages and in various tissues.

Authors:  N Sakashita; A Miyazaki; M Takeya; S Horiuchi; C C Chang; T Y Chang; K Takahashi
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

5.  Monocyte proliferation induced by modified serum is associated with endogenous M-CSF production: evidence for involvement of a signalling pathway via scavenger receptors.

Authors:  E Asakura; N Tojo; T Tanabe
Journal:  Cell Prolif       Date:  1999-08       Impact factor: 6.831

6.  The catalytically active secretory phospholipase A2 type IIA is involved in restenosis development after PTCA in human coronary arteries and generation of atherogenic LDL.

Authors:  Aleksandra A Korotaeva; Elena V Samoilova; Aleksander I Kaminny; Aleksandra A Pirkova; Therese J Resink; Paul Erne; Nina V Prokazova; Vsevolod A Tkachuk; Evgeny I Chazov
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

Review 7.  Clinical significance of the physicochemical properties of LDL in type 2 diabetes.

Authors:  P G Scheffer; T Teerlink; R J Heine
Journal:  Diabetologia       Date:  2005-04-14       Impact factor: 10.122

8.  Abnormal serum lysophospholipids in multiple myeloma patients.

Authors:  T Sasagawa; M Okita; J Murakami; T Kato; A Watanabe
Journal:  Lipids       Date:  1999-01       Impact factor: 1.880

9.  Comparison of macrophage responses to oxidized low-density lipoprotein and macrophage colony-stimulating factor (M-CSF or CSF-1).

Authors:  J A Hamilton; R Byrne; W Jessup; V Kanagasundaram; G Whitty
Journal:  Biochem J       Date:  2001-02-15       Impact factor: 3.857

10.  Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor.

Authors:  C H MacPhee; K E Moores; H F Boyd; D Dhanak; R J Ife; C A Leach; D S Leake; K J Milliner; R A Patterson; K E Suckling; D G Tew; D M Hickey
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.